Skip to main content

Table 4 Multivariate regression analyses of the SLC2A10 haplotype H4 with PAD in type 2 diabetes.

From: SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10and PAD in type 2 diabetes

Risk factors Effect estimate OR (95% CI) P-values
Age (per year) 0.0812 1.09(1.04,1.13) 3 × 10 -4
Male -0.0456 0.91(0.38,2.19) 0.83
Hemoglobin A1C (per 1%increase) 0.1046 1.11(0.91,1.36) 0.31
Duration of diabetes (per year) 0.0467 1.05(1,1.1) 0.04
Triglyceride
(per increase of 1mM)
0.2118 1.24(0.79,1.92) 0.34
Total cholesterol
(per increase of 1mM)
-0.1952 0.82(0.54,1.26) 0.36
Systolic blood pressure
(per 1 mmHg increase)
0.0463 1.05(1.03,1.07) 1.9 × 10 -5
Current smoker -0.2913 0.56(0.22,1.44) 0.22
Body mass index (per kg/m2 increase) -0.0564 0.95(0.83,1.08) 0.39
H4 haplotype 3.4171 30.47(4.47-208.5) 5 × 10 -4
  1. PAD, peripheral artery disease; OR, odds ratio; CI, confidence interval